iQuit Mindfully: Text Messaging for Smoking Cessation



Status:Completed
Conditions:Smoking Cessation
Therapuetic Areas:Pulmonary / Respiratory Diseases
Healthy:No
Age Range:18 - 65
Updated:1/10/2019
Start Date:January 18, 2017
End Date:October 3, 2017

Use our guide to learn which trials are right for you!

iQuit Mindfully: A Randomized Controlled Trial of Mindfulness-based Smoking Cessation Enhanced With Mobile Technology

The purpose of this study is to investigate text messaging as a way to enhance
mindfulness-based treatment for smoking cessation.

This study is a pilot investigation of mindfulness-based smoking cessation treatment
incorporating between-session text messaging ("iQuit Mindfully"). Participants will be
randomly assigned to one of two groups: Mindfulness-based Addiction Treatment (MBAT) or iQuit
Mindfully (MBAT with the addition of between-session text messages).

All participants will receive in-person group treatment based on the 8-week MBAT protocol in
addition to nicotine patch therapy and self-help materials. Participants assigned to iQuit
Mindfully will receive additional support via text messaging. Assessments will occur at
baseline, at each of the weekly in-person visits, at end of treatment, and at 1-month
follow-up. Feasibility, smoking abstinence, mindfulness practice, and indicators of tobacco
dependence and psychological well-being will be assessed.

Inclusion Criteria:

- age 18-65 years

- current smoker with history of >5 cigarettes/day for past year (and expired carbon
monoxide >6 parts per million [ppm])

- motivated to quit within next 30 days

- valid home address in the greater Atlanta, Georgia area

- functioning telephone number

- own a mobile phone with text messaging capacity

- can speak, read, and write in English

- at least a sixth-grade level of health literacy

Exclusion Criteria:

- contraindication for nicotine patch

- active substance abuse/dependence

- regular use of tobacco products other than cigarettes

- current use of tobacco cessation medications

- pregnancy or lactation

- household member enrolled in the study

- current diagnosis of schizophrenia or bipolar disorder, or use of antipsychotic
medications

- clinically significant depressive symptoms
We found this trial at
1
site
Atlanta, Georgia 30302
?
mi
from
Atlanta, GA
Click here to add this to my saved trials